These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20054971)

  • 1. Bacterial toxins as immunomodulators.
    Donaldson DS; Williams NA
    Adv Exp Med Biol; 2009; 666():1-18. PubMed ID: 20054971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune Diseases.
    Zhao Y; Huang J; Yuan X; Peng B; Liu W; Han S; He X
    Toxins (Basel); 2015 May; 7(5):1749-64. PubMed ID: 25996605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
    Marciani DJ
    Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of statins on MHC class I expression.
    Singh P; Kohr D; Kaps M; Blaes F
    Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial toxins as versatile delivery vehicles.
    de Haan L; Hirst TR
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):269-78. PubMed ID: 11926133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo.
    Comer JE; Chopra AK; Peterson JW; König R
    Infect Immun; 2005 Dec; 73(12):8275-81. PubMed ID: 16299324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Toxins Are a Never-Ending Source of Surprises: From Natural Born Killers to Negotiators.
    Lopez Chiloeches M; Bergonzini A; Frisan T
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34204481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
    Ulivieri C; Baldari CT
    Pharmacol Res; 2014 Oct; 88():41-52. PubMed ID: 24657239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods to Study Rho GTPases Using Bacterial Toxins.
    Schmidt G
    Methods Mol Biol; 2018; 1821():141-154. PubMed ID: 30062410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of bacterial toxins in preventive and curative therapy].
    Alexandru I
    Bacteriol Virusol Parazitol Epidemiol; 2004; 49(1-2):85-7. PubMed ID: 16752757
    [No Abstract]   [Full Text] [Related]  

  • 11. Modified anthrax fusion proteins deliver HIV antigens through MHC Class I and II pathways.
    McEvers K; Elrefaei M; Norris P; Deeks S; Martin J; Lu Y; Cao H
    Vaccine; 2005 Jul; 23(32):4128-35. PubMed ID: 15964481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecules of infectious agents as immunomodulatory drugs.
    Lavelle EC; McGuirk P; Mills KH
    Curr Top Med Chem; 2004; 4(5):499-508. PubMed ID: 14965301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of bacterial toxins with host defence: molecular mechanisms of immunomodulatory signalling.
    Backert S; König W
    Int J Med Microbiol; 2005 Dec; 295(8):519-30. PubMed ID: 16325548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells.
    Flaherty RA; Lee SW
    J Vis Exp; 2016 Aug; (114):. PubMed ID: 27585035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormones as immunomodulators of disease.
    Lahita RG
    Ann N Y Acad Sci; 1993 Jun; 685():278-87. PubMed ID: 8363231
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments in mucosal immunomodulatory adjuvants.
    Harandi AM; Sanchez J; Eriksson K; Holmgren J
    Curr Opin Investig Drugs; 2003 Feb; 4(2):156-61. PubMed ID: 12669375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial toxins: friends or foes?
    Schmitt CK; Meysick KC; O'Brien AD
    Emerg Infect Dis; 1999; 5(2):224-34. PubMed ID: 10221874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin S inhibitors as novel immunomodulators.
    Thurmond RL; Sun S; Karlsson L; Edwards JP
    Curr Opin Investig Drugs; 2005 May; 6(5):473-82. PubMed ID: 15912960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for T cell receptor-HLA class II molecule interaction in the response to superantigenic bacterial toxins.
    Fleischer B; Mittrücker HW
    Eur J Immunol; 1991 May; 21(5):1331-3. PubMed ID: 2037017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxins A and B of Clostridium difficile.
    Wolfhagen MJ; Torensma R; Fluit AC; Verhoef J
    FEMS Microbiol Rev; 1994 Jan; 13(1):59-64. PubMed ID: 8117467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.